Status:

TERMINATED

Tannin Specific Natural Extract for COVID-19 Infection

Lead Sponsor:

Hospital de Clinicas José de San Martín

Collaborating Sponsors:

SILVATEAM

Conditions:

COVID-19

SARS-CoV 2

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

There is an urgent need to evaluate interventions that could be effective against the infection with SARS-CoV 2. Tannins based wood extracts are an inexpensive and safe product with protective effect ...

Detailed Description

The epidemic of 2019 novel coronavirus (causing the disease Covid-19) has expanded from Wuhan throughout China and is being exported to a growing number of countries, some of which have seen onward tr...

Eligibility Criteria

Inclusion

  • Over 18 years of age hospitalized in the general hospitalization room, who meet the definition of "Confirmed case COVID-19" (https://www.argentina.gob.ar/salud/coronavirus-COVID-19/definicion -of-case)

Exclusion

  • Pregnancy
  • Lactancy
  • Hypersensitivity to polyphenols
  • Patients unable to receive oral medication (severe cognitive impairment, assisted ventilation, impaired state of consciousness)
  • Lack of consent
  • Participation in any other interventional clinical trial

Key Trial Info

Start Date :

June 12 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2020

Estimated Enrollment :

124 Patients enrolled

Trial Details

Trial ID

NCT04403646

Start Date

June 12 2020

End Date

November 1 2020

Last Update

December 22 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital de Clinicas

Buenos Aires, Argentina, C1120AAF

Tannin Specific Natural Extract for COVID-19 Infection | DecenTrialz